All In Biotech

Drug Trial Radar · NCT01255722

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography (X-ACT Study)

Last checked: Nov 19, 2026Latest source record: Dec 16, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 468 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

468

Actual

Start

Nov 2010

Primary completion

Sep 2012

Study completion Sep 2012

Sponsor

Lead sponsor
GuerbetIndustry
Sponsor type
Industry
First posted
Dec 7, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate the (statistical) non-inferiority of iobitridol (Xenetix® 350) when compared to contrast agents with higher iodine concentrations, iopromide (Ultravist® 370) and iomeprol (Iomeron® 400) in terms of coronary CT scan evaluability (quality and interpretability of images).

Conditions

  • Coronary Artery Disease

Interventions

  • iobitridolDrug

    single IV injection

  • iopromideDrug

    Single IV injection

  • iomeprolDrug

    Single IV injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Patients With Evaluable CT Scans i.e. Allowing Identification of Coronary Artery Stenosis According to Off-site Reading AssessmentTime frame: < 24h

Locations

23 sites in 5 countries. Site status is shown where the registry gives one.

  • CHU Angers

    Angers, France

  • CHU de la Cavale Blanche

    Brest, France

  • Centre Chirurgical Marie Lannelongue

    Le Plessis-Robinson, France

  • La Timone Adultes

    Marseille, France

  • Hopital Cochin

    Paris, France

  • Haut-Lévêque / Radiologie

    Pessac, France

  • CHU Pontchaillou

    Rennes, France

  • CHU Rouen - Hopital Charles Nicolle

    Rouen, France

  • Centre Cardiologique du Nord

    Saint-Denis, France

  • Institut für Radiologie Universitätsklinikum Charité

    Berlin, Germany

  • University Hospital Erlangen

    Erlangen, Germany

  • Elisabeth-Krankenhaus Hospital

    Essen, Germany

  • University Hospital Mannheim

    Mannheim, Germany

  • University Hospital LMU

    Munich, Germany

  • Universitätsklinik Ulm

    Ulm, Germany

  • Ospedale A.Perrino U.O. di radiodiagnostica

    Brindisi, Italy

  • Ospedale del Delta

    Ferrara, Italy

  • Sapienza-universita di Roma

    Rome, Italy

  • Ospedale civile Maggiore du Verona Borgo

    Verona, Italy

  • Hospital Vall d'Hebron

    Barcelona, Spain

  • Hospital Clinico San Carlos

    Madrid, Spain

  • Complejo Hospitalario Universitario de Santiago de Compostela

    Santiago de Compostela, Spain

  • Institut für Radiologie

    Sankt Gallen, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.